FENDX TECHNOLOGIES Business Summary

FendX Technologies Inc. is a nanotechnology-driven firm specializing in the development and commercialization of surface protection coatings designed to inhibit the transmission of pathogens. The company’s revenue model is primarily built on a licensing and royalty-based strategy, complemented by strategic manufacturing partnerships—most notably with Dunmore for its flagship REPELWRAP™ film—and recent 2026 collaborations with Aquaox for eco-friendly antimicrobial agents. Business segments are categorized into healthcare-grade surface protection, high-traffic commercial environments such as transportation and education, and specialized medical applications like Foley catheters. In a competitive landscape populated by firms such as NanoSeptic, Kastus, and Bio-Gate AG, FendX distinguishes itself through its proprietary 'omniphobic' mechanical repulsion technology, positioning the company as a passive, non-toxic alternative to traditional chemical-leaching antimicrobial coatings. The leadership team is spearheaded by President and CEO Dr. Carolyn Myers, an industry veteran with over 30 years of experience in the pharmaceutical and biotech sectors, including executive roles at Allergan and Forest Laboratories. The company’s technical foundation is anchored by Co-Founder and Director Dr. Sahar Sam, who led the initial development of the core nanotechnology at McMaster University and continues to drive innovation. The executive suite is further supported by CFO Rose Zanic, a specialist in corporate finance and public listings, and Tash Yousuf, Director of Nanotechnology Development and Operations. The board of directors includes experienced independent members such as Stephen Randall and Pierre Soulard, while the company maintains strong academic ties to McMaster University’s research chairs, Dr. Leyla Soleymani and Dr. Tohid Didar, who serve as key scientific advisors and co-inventors of the core technology.